Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

…, D Abramovicz, D Blockmans, A Mathieu… - Arthritis & …, 2002 - Wiley Online Library
Objective Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE)
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients

…, E De Ramón, M Galeazzi, HJ HAGA, A Mathieu… - Medicine, 1993 - journals.lww.com
Systemic Lupus Erythematosus: Clinical and Immunologic Patte... : Medicine Systemic Lupus
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

…, A Fernández-Nebro, M Galeazzi, M Valen, A Mathieu… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …

Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients

…, A Fernández-Nebro, M Galeazzi, HJ Haga, A Mathieu… - Medicine, 1999 - journals.lww.com
… II Cattedra di Reumatologia, Università di Cagliari, Cagliari, Italy: Alessandro Mathieu,
Giuseppe Passiu, Giovanni Sanna, and Alberto Cauli. Service de Rhumatologie, Cliniques …

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

…, H Laing, MA Khamashta, A Mathieu… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To apply the new American College of Rheumatology nomenclature for
neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalence of the different …

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis …

…, D Abramovicz, D Blockmans, A Mathieu… - Arthritis & …, 2004 - Wiley Online Library
Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …

Overexpression of the cytokine BAFF and autoimmunity risk

…, MG Danieli, S Del Giacco, A Mathieu… - … England Journal of …, 2017 - Mass Medical Soc
Background Genomewide association studies of autoimmune diseases have mapped hundreds
of susceptibility regions in the genome. However, only for a few association signals has …

Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta‐analysis

…, M Inanc, L Massardo, A Mathieu… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P
proteins (anti‐P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for …

The pathogenetic role of HLA-B27 and its subtypes

MA Khan, A Mathieu, R Sorrentino, N Akkoc - Autoimmunity reviews, 2007 - Elsevier
The strong association between HLA-B27 and ankylosing spondylitis has been known for
more than 33 years, but the enigma of the pathogenetic role of the gene and its product has …

Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

…, E Arrigoni, E Bravi, P Migliorini, A Mathieu… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …